Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

Florida Cancer Specialists & Research Institute, LLC (FCS) is among the first oncology providers in Florida selected to ...

South Korea's Hyundai ADM Bio plans to launch global clinical trials of its new drug, Penetrium, for rheumatoid arthritis and ...

North East patients are among the first in the UK to trial Lutetium (177Lu) rhPSMA-10.1, a new targeted treatment for ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

A newly developed long-term prediction model demonstrated greater accuracy in estimating prostate cancer–specific mortality compared with existing risk assessment tools. Unlike traditional ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

A North Island College (NIC) biology instructor has received a $10,000 grant from Prostate Cancer Foundation Canada to give ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.